IBM uses AI to evaluate risk of developing genetic diseases

In a study published in the journal Nature Communications, scientists at IBM, the Broad Institute of MIT and Harvard, and health tech company Color find evidence the presence of genetic mutations isn’t a reliable precursor to genetic diseases. They claim diseases can so greatly be influenced by other factors that the risk in carriers is sometimes as low as that of noncarriers.

Read More